ROBOTERA Tops Embodied AI Benchmark RoboDojo Without Additional Data or Agent RSI
BEIJING, Oct. 9, 2026 /PRNewswire/ -- ROBOTERA's World Action Model (WAM), VPP2 (Video Prediction Policy 2), has ranked No. 1 on RoboDojo without additional data or agent-based reinforcement self-improvement (Agent RSI). Developed by the University...
GEP NAMED AS A LEADER IN SUPPLY CHAIN PLATFORMS EVALUATION, RECEIVES HIGHEST SCORE POSSIBLE IN INNOVATION CRITERION
GEP recognized for its investments in AI-native architecture, agentic AI, and autonomous decision-making supplier networks Recognition follows recent leadership positions from Gartner, IDC and The Hackett Group across procurement, direct spend and...
SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
MILAN, Oct. 4, 2026 /PRNewswire/ -- At the European Association for the Study of Diabetes (EASD) 2026, SiBionics presented "See More, Act Earlier," connecting continuous sensing with future diabetes care. Three exhibition chapters shaped this...
Results from Phase III Study of Trastuzumab Botidotin versus T-DM1 in HER2-Positive Breast Cancer Published in JCO
CHENGDU, China, Sept. 14, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or "the Company", 6990.HK) announced that results from the phase III registrational study of its novel human epidermal growth factor...
Akeso 2026 Interim Results: Strong Commercialization Momentum; IO2.0+ Global Strategy Redefining Clinical Standards; Bispecific Advancement in ADC, I&I and Alzheimer's
HONG KONG, Aug. 28, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced its 2026 interim results. During the reporting period, the Company achieved record-high drug sales revenue, further advanced its global...
Ookla Study in Manila: Carrier VoLTE Networks Prove to Outperform OTT Apps in Voice Quality and Reliability
MANILA, Philippines, July 27, 2026 /PRNewswire/ -- Ookla's comprehensive controlled network test reveals that traditional mobile operator networks deliver a measurably superior voice experience compared to Over-the-Top (OTT) applications like...
AGIBOT WORLD CHALLENGE 2026 Advances Embodied AI Competition from Simulation to Real-Robot Testing at ICRA 2026
VIENNA, June 5, 2026 /PRNewswire/ -- AGIBOT, a leading embodied AI company, hosted AGIBOT WORLD CHALLENGE 2026 alongside ICRA 2026 in Vienna, bringing together 526 research and enterprise teams from 27 countries to compete across two embodied AI...
Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences' Zhou Jian Comments on Potential for Patients With FGFR2 Alterations
CHICAGO, June 2, 2026 /PRNewswire/ -- At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, 3H Pharmaceuticals released new clinical data for its wholly owned candidate, 3HP-2827. The ongoing study focuses on patients with...
Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
High Impact Session presented at Heart Rhythm Society's Congress in Chicago First time showing results of new Less Invasive approach Improvement in Left Ventricular Ejection Fraction (LVEF), 6 Minute Walk Test (6MWT), Quality of Life (QOL) and New...
Co-PSMA: Cu-64 SAR-bisPSMA more than doubled prostate cancer lesion and patient detection vs. Ga-68 PSMA-11 in head-to-head trial
HIGHLIGHTS Abstract outlining key findings from the Co-PSMA Investigator-Initiated Trial (IIT) has been released. The study was led by Prof Louise Emmett at St Vincent's Hospital Sydney, and the abstract was accepted for oral presentation at the...